MMP- 9 levels have been reported to increase in mice following EAE and in the cerebrospinal fluid of MS patients [4, 5, 54] while MMP-9 inhibitors have been shown to be protective in EAE [55]. The gene discussed is MMP9; the disease is myeloid sarcoma.